Showing results (31-40 of 190) with videos related to
Sort By:
Pageof 19
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 4, 2019
The Impact of the Fecal Microbiome on Cancer ImmunotherapyAfaf E G Osman, Jason J LukeClinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2024
Unraveling the Therapeutic Benefit of Sequenced Chemo-immunotherapyPaolo D A Vignali, Jason J LukeJournal for Immunotherapy of Cancer|February 15, 2026
Unlocking the promise of innate biology through the HLA-G/ILT2/ILT4 pathwayCourtney Beers, Robert L Ilaria, Jason J LukeClinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2020
PD-1 Blockade in Chinese versus Western Patients with MelanomaAlexander N Shoushtari, Riyue Bao, Jason J LukeJournal for Immunotherapy of Cancer|February 7, 2023
Targeting Cbl-b in cancer immunotherapyRyan C Augustin, Riyue Bao, Jason J LukeClinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2018
Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon AxisBrian W Labadie, Riyue Bao, Jason J LukeFrontiers in Oncology|June 28, 2021
Therapeutic Advancements Across Clinical Stages in Melanoma, With a Focus on Targeted ImmunotherapyClaudia Trojaniello, Jason J Luke, Paolo A AsciertoClinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2022
Old Dog, New Trick: A Tumor-Intrinsic Role for PD-1 in Chemoresistant Tumor SubclonesRyan C Augustin, Riyue Bao, Jason J LukeHealth Affairs (Project Hope)|March 9, 2011
Episode-based payment for cancer care: a proposed pilot for MedicarePeter B Bach, Joshua N Mirkin, Jason J LukeCancers|November 13, 2021
Immune Checkpoint Inhibitors for Genitourinary Cancers: Treatment Indications, Investigational Approaches and BiomarkersBrian W Labadie, Arjun V Balar, Jason J LukePageof 19